Skip to main content
VVT MED INC. logo

VVT MED INC. — Investor Relations & Filings

Ticker · VVTM ISIN · CA91841T1084 TSXV Manufacturing
Filings indexed 362 across all filing types
Latest filing 2017-05-10 Regulatory Filings
Country CA Canada
Listing TSXV VVTM

About VVT MED INC.

https://www.vvtmed.com/

VVT MED INC. develops, manufactures, and commercializes minimally invasive, non-thermal, non-tumescent (NT-NT) solutions for the treatment of varicose veins and chronic venous disorders. The company's technology centers on the ScleroSafe Platform, a patented delivery system for Endovenous Chemical Ablation (ECA). ScleroSafe is designed to simplify procedures, shorten treatment times, and minimize patient recovery compared to traditional surgical and ablation methods. Products like ScleroSafe and V-Block, which treats severely dilated Great Saphenous Vein conditions, offer enhanced safety and efficacy. The platform holds regulatory clearances including FDA 510(k) and CE approval.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2017-05-10 English
Other.pdf
Regulatory Filings
2017-04-27 English
Management information circular - English.pdf
Regulatory Filings
2017-04-26 English
News release - English.pdf
Regulatory Filings
2017-04-25 English
Annual information form - English.pdf
Regulatory Filings
2017-03-29 English
52-109F1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings
2017-03-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.